Point Biopharma Global Inc (PNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1987 | 09-1987 | 06-1987 | 12-1986 | 12-1985 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 10,545 | N/A | N/A | 10,846 | 13,243 |
| Depreciation Amortization | 5,520 | N/A | N/A | 5,020 | 4,755 |
| Other Working Capital | 1,955 | N/A | N/A | 2,795 | 2,495 |
| Other Operating Activity | 2,742 | 0 | 0 | 2,741 | 3,749 |
| Operating Cash Flow | $20,762 | $N/A | $N/A | $21,402 | $24,242 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 36,564 | 0 | 0 | 526 | 729 |
| Investing Cash Flow | $36,564 | $N/A | $N/A | $526 | $729 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 3,080 | 0 | 0 | 1,077 | 1,065 |
| Financing Cash Flow | $3,080 | $N/A | $N/A | $1,077 | $1,065 |
| Exchange Rate Effect | N/A | N/A | N/A | 2,012 | N/A |
| Beginning Cash Position | 49,997 | N/A | N/A | 27,204 | 35,809 |
| End Cash Position | 7,329 | N/A | N/A | -5,276 | -10,838 |
| Net Cash Flow | $3,925 | $N/A | $N/A | $66 | $3,037 |
| Free Cash Flow | |||||
| Operating Cash Flow | 20,762 | N/A | N/A | 21,402 | 24,242 |
| Free Cash Flow | 20,762 | 0 | 0 | 21,402 | 24,242 |